Literature DB >> 16474417

Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.

Erin J Whalen1, James N Bates, Alan Kim Johnson, Stephen J Lewis.   

Abstract

The beta-adrenoceptor agonist, isoprenaline, elicits vasodilation and tachycardia in anesthetized rats via activation of propranolol-sensitive beta1- and beta2-adrenoceptors and also by propranolol-insensitive beta1- and beta3-adrenoceptors. The aim of this study was to determine whether the relative contribution of propranolol-sensitive and -insensitive beta-adrenoceptors to the changes in heart rate (HR) and vascular resistances elicited by isoprenaline is altered after blockade of nitric oxide (NO) synthase, in pentobarbital-anesthetized rats. The hemodynamic responses elicited by isoprenaline (0.1 and 0.5 microg kg(-1), i.v.) were determined before and after injection of saline or the NO synthase inhibitor, N(G)-nitro-L-arginine methylester (L-NAME, 50 micromol kg(-1), i.v.), and again after injection of the beta1- and beta2-adrenoceptor antagonist, propranolol (1 mg kg(-1), i.v.). The responses elicited by the above doses of isoprenaline were also determined before and during infusion of the alpha1-adrenoceptor agonist, phenylephrine (3 microg kg(-1) min(-1), i.v.), and again 15-20 min after injection of propranolol (1.0 mg kg(-1), i.v.). Both doses of isoprenaline elicited tachycardia and reductions in vascular resistances. Propranolol eliminated the responses elicited by the lower dose of isoprenaline and substantially diminished the responses elicited by the higher dose of the beta1-, beta2- and beta3-adrenoceptor agonist. The maximal vasodilator responses elicited by both doses of isoprenaline were not diminished whereas the maximal increases in HR were higher after injection of L-NAME. The ability of propranolol to diminish the hemodynamic actions of isoprenaline was substantially diminished in L-NAME-treated rats, whereas propranolol retained its potency in rats that received an equi-pressor infusion of the alpha1-adrenoceptor agonist, phenylephrine. The finding that the maximal vasodilator responses elicited by isoprenaline were not diminished by L-NAME suggests that the vasodilation elicited by this drug was due to direct activation of beta-adrenoceptors on vascular smooth muscle and that the full compliment of isoprenaline-sensitive receptors was not changed after inhibition of NO synthesis. However, these results suggest that the activities of propranolol-sensitive beta-adrenoceptors are downregulated, whereas propranolol-insensitive beta-adrenoceptors are upregulated upon the loss of exposure to endothelial nitrosyl factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474417      PMCID: PMC1751502          DOI: 10.1038/sj.bjp.0706675

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

Review 1.  Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins.

Authors:  Audrey Claing; Stéphane A Laporte; Marc G Caron; Robert J Lefkowitz
Journal:  Prog Neurobiol       Date:  2002-02       Impact factor: 11.685

Review 2.  (S)NO signals: translocation, regulation, and a consensus motif.

Authors:  J S Stamler; E J Toone; S A Lipton; N J Sucher
Journal:  Neuron       Date:  1997-05       Impact factor: 17.173

3.  Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.

Authors:  A J Kaumann; S Engelhardt; L Hein; P Molenaar; M Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-01       Impact factor: 3.000

4.  In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac beta(1)- or beta(2)-adrenoceptors.

Authors:  E J Whalen; S J Lewis
Journal:  Eur J Pharmacol       Date:  1999-10-15       Impact factor: 4.432

5.  Beta-adrenoceptor dysfunction after inhibition of NO synthesis.

Authors:  E J Whalen; A K Johnson; S J Lewis
Journal:  Hypertension       Date:  2000-09       Impact factor: 10.190

6.  Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.

Authors:  Andreas Bundkirchen; Klara Brixius; Birgit Bölck; Robert H G Schwinger
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

7.  Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors.

Authors:  A H Danser; R de Vries; R G Schoemaker; P R Saxena
Journal:  J Hypertens       Date:  1998-02       Impact factor: 4.844

8.  (-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  Blockade of beta-adrenoceptors enhances cAMP signal transduction in vivo.

Authors:  E J Whalen; A K Johnson; S J Lewis
Journal:  Eur J Pharmacol       Date:  1998-08-21       Impact factor: 4.432

10.  The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.

Authors:  C Gauthier; V Leblais; L Kobzik; J N Trochu; N Khandoudi; A Bril; J L Balligand; H Le Marec
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

View more
  4 in total

1.  Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice.

Authors:  Guy Katz; Assad Khoury; Efrat Kurtzwald; Edith Hochhauser; Eyal Porat; Asher Shainberg; Jonathan G Seidman; Christine E Seidman; Abraham Lorber; Michael Eldar; Michael Arad
Journal:  Heart Rhythm       Date:  2010-07-08       Impact factor: 6.343

2.  S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Ryan B Gruber; Benjamin Gaston; Tristan H J Lewis; Alan Grossfield; James M Seckler; Yee-Hsee Hsieh; James N Bates; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

3.  Dietary structured lipids and phytosteryl esters: blood lipids and cardiovascular status in spontaneously hypertensive rats.

Authors:  Byung Hee Kim; Kevin D Sandock; Tom P Robertson; Stephen J Lewis; Casimir C Akoh
Journal:  Lipids       Date:  2007-11-06       Impact factor: 1.880

4.  Nitrosyl factors play a vital role in the ventilatory depressant effects of fentanyl in unanesthetized rats.

Authors:  James M Seckler; Alan Grossfield; Walter J May; Paulina M Getsy; Stephen J Lewis
Journal:  Biomed Pharmacother       Date:  2021-12-22       Impact factor: 6.529

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.